Skip to main content

Schizophrenia & Psychotic Disorders

May 18, 2018
Leslie Citrome, MD, MPH, discusses the link between schizophrenia and diabetes, the role of metabolic syndrome, weight gain from antipsychotics, and interventions for patients with schizophrenia.
January 05, 2018
Psych Congress co-chair Rakesh Jain, MD, MPH, explains the importance of the Abnormal Involuntary Movement Scale (AIMS) exam in the diagnosis and monitoring of patients with tardive dyskinesia.
March 02, 2017
This video is a component of an accredited CME session presented at Elevate by Psych Congress 2017. The educational activity is supported by educational grants from Alkermes, Inc. and Otsuka America Pharmaceuticals, Inc.
March 02, 2017
This video is a component of an accredited CME session presented at Elevate by Psych Congress 2017. The educational activity is supported by educational grants from Alkermes, Inc. and Otsuka America Pharmaceuticals, Inc.
January 17, 2017
Joseph P. McEvoy, MD, discusses how cannabis affects the risk of schizophrenia and the course of the disease.
January 05, 2017
Joseph P. McEvoy, MD, discusses new strategies for treating tardive dyskinesia. Dr. McEvoy is Professor of Psychiatry and Health Behavior and the I. Clark Case Chair in Psychotic Disorders at the Medical College of Georgia.
November 23, 2016
Joseph P. McEvoy, MD, discusses the reasons why specialized treatment programs are important after a first episode of psychosis. 
July 11, 2016
Psych Congress steering committee member Rakesh Jain, MD, MPH, discussed the advantages of treating patients with schizophrenia with long-acting injectable treatments, as part of a presentation at the Psych Congress 1-Day Regional Meeting in Milwaukee.
July 11, 2016
Psych Congress steering committee member Rakesh Jain, MD, MPH, discussed how to talk to patients with schizophrenia about using long-acting injectable treatments, as part of a presentation at the Psych Congress 1-Day Regional Meeting in Milwaukee. 
August 03, 2015
Peter Weiden, MD, and Charles Raision, MD, talk about how to do cognitive behavioral therapy with a group of people who have patterns of cognitive dysfunction. Click here to read the transcript. 
Back to Top